Cargando…

Biology and Clinical Applicability of Plasma Thymus and Activation-Regulated Chemokine (TARC) in Classical Hodgkin Lymphoma

SIMPLE SUMMARY: Thymus and activation-regulated chemokine (TARC) is an important biomarker in classical Hodgkin lymphoma and several other diseases. The exact role of TARC in the pathogenesis of these diseases, as well as its therapeutic potential, is not yet fully understood. Understanding the role...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zijtregtop, Eline A. M., van der Strate, Iris, Beishuizen, Auke, Zwaan, Christian M., Scheijde-Vermeulen, Marijn A., Brandsma, Arianne M., Meyer-Wentrup, Friederike
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923750/ https://www.ncbi.nlm.nih.gov/pubmed/33672548 http://dx.doi.org/10.3390/cancers13040884

Ejemplares similares

Plasma thymus and activation‐regulated chemokine (TARC) as diagnostic marker in pediatric Hodgkin lymphoma
por: Zijtregtop, Eline A. M., et al.
Publicado: (2020)

Thymus and activation‐regulated chemokine (TARC) as treatment response marker for paediatric Hodgkin lymphoma: A pilot study
por: Zijtregtop, Eline A. M., et al.
Publicado: (2022)

The Prognostic Value of Eight Immunohistochemical Markers Expressed in the Tumor Microenvironment and on Hodgkin Reed-Sternberg Cells in Pediatric Patients With Classical Hodgkin Lymphoma
por: Zijtregtop, Eline A. M., et al.
Publicado: (2022)

T027: High serum levels of Thymus and Activation Related Chemokine (TARC) precede Hodgkin lymphoma diagnosis by several years
por: Diepstra, Arjan, et al.
Publicado: (2022)

Machine Learning Logistic Regression Model for Early Decision Making in Referral of Children with Cervical Lymphadenopathy Suspected of Lymphoma
por: Zijtregtop, Eline A. M., et al.
Publicado: (2023)

Thymus and activation-regulated chemokine (TARC)/CCL17 and IgE are associated with elderly asthmatics
por: Jo, Kyung Mi, et al.
Publicado: (2018)

The value of thymus and activation related chemokine immunohistochemistry in classic Hodgkin lymphoma diagnostics
por: Kilsdonk, Melvin, et al.
Publicado: (2022)

Nivolumab plus Brentuximab vedotin +/- bendamustine combination therapy: a safe and effective treatment in pediatric recurrent and refractory classical Hodgkin lymphoma
por: Greve, Patrick, et al.
Publicado: (2023)

Blood‐circulating EV‐miRNAs, serum TARC, and quantitative FDG‐PET features in classical Hodgkin lymphoma
por: Drees, Esther E. E., et al.
Publicado: (2022)

Improved survival for adolescents and young adults with Hodgkin lymphoma and continued high survival for children in the Netherlands: a population‐based study during 1990–2015
por: Reedijk, Ardine M. J., et al.
Publicado: (2020)

Serum canine thymus and activation‐regulated chemokine (TARC/CCL17) concentrations correlate with disease severity and therapeutic responses in dogs with atopic dermatitis
por: Asahina, Ryota, et al.
Publicado: (2020)

Significance of E-lesions in Hodgkin lymphoma and the creation of a new consensus definition: a report from SEARCH
por: Zijtregtop, Eline A. M., et al.
Publicado: (2023)

Interleukin-4 induction of the CC chemokine TARC (CCL17) in murine macrophages is mediated by multiple STAT6 sites in the TARC gene promoter
por: Liddiard, Kate, et al.
Publicado: (2006)

TOF and TARC
Publicado: (2000)

P034: Correlation between MTV, TLG and Serum TARC Concentration in Classical Hodgkin Lymphoma during First-Line Treatment
por: Romano, Ilaria, et al.
Publicado: (2022)

Interim thymus and activation regulated chemokine versus interim (18)F‐fluorodeoxyglucose positron‐emission tomography in classical Hodgkin lymphoma response evaluation
por: Plattel, Wouter J., et al.
Publicado: (2020)

P1302: INTEGRATION OF ROUTINE RNA AND WHOLE-EXOME SEQUENCING AND FLOW CYTOMETRY IMPROVES THE DIAGNOSTIC WORKUP OF PEDIATRIC LYMPHOMAS
por: Westera, L., et al.
Publicado: (2022)

Is CC Chemokine Ligand 17 (TARC) Driving Disease Progression in Chronic Obstructive Pulmonary Disease?
por: Girkin, Jason
Publicado: (2022)

Memorandum: Completion of the TARC experiment
por: CERN. Geneva. SPS-LEAR Experiments Committee
Publicado: (1997)

CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma
por: Cuccaro, Annarosa, et al.
Publicado: (2016)

Members of the TARC Collaboration pictured with their apparatus
Publicado: (1997)

The TARC Experiment at CERN: Modern Alchemy
por: Revol, Jean-Pierre
Publicado: (2017)

Determination of the impurity content of the lead assembly for the TARC experiment
por: Embid, M, et al.
Publicado: (1997)

Increased expression of chemokines DC-CK1, ELC and TARC by dendritic cells and in synovium from patients with rheumatoid arthritis
por: Radstake, T, et al.
Publicado: (2004)

Determination of the beam geometry in the fast extraction mode for the TARC experiment
por: Embid, M, et al.
Publicado: (1997)

Analytical Performance of a Novel Latex Turbidimetric Immunoassay, “Nanopia TARC”, for TARC/CCL17 Measurement: A Retrospective Observational Study
por: Yamashita, Keita, et al.
Publicado: (2023)

Determination of the beam characteristics in the slow extraction mode in the TARC experiment
por: Abánades, A, et al.
Publicado: (1997)

Triggering of FcGR during dendritic cell maturation leads to a decreased expression of the chemokines DC-CK1, ELC and TARC
por: Radstake, TRDJ, et al.
Publicado: (2004)

Central venous catheter–associated complications in pediatric patients diagnosed with Hodgkin lymphoma: implications for catheter choice
por: van den Bosch, Ceder H., et al.
Publicado: (2022)

The Contribution of Chemokines and Migration to the Induction of Central Tolerance in the Thymus
por: Hu, Zicheng, et al.
Publicado: (2015)

Role of Thymus and Activation-Regulated Chemokine in Allergic Asthma
por: Luu Quoc, Quang, et al.
Publicado: (2022)

Update on geometric details of the lead assembly and of the experimental area for the TARC experiment
por: Revol, Jean-Pierre
Publicado: (1996)

CCL17/TARC and CCR4 expression in Merkel cell carcinoma
por: Rasheed, Kashif, et al.
Publicado: (2018)

Risk and Response Adapted Treatment Guidelines for Managing First Relapsed and Refractory Classical Hodgkin Lymphoma in Children and Young People. Recommendations from the EuroNet Pediatric Hodgkin Lymphoma Group
por: Daw, Stephen, et al.
Publicado: (2020)

Loss of GRHL3 leads to TARC/CCL17-mediated keratinocyte proliferation in the epidermis
por: Goldie, Stephen J., et al.
Publicado: (2018)

Elevated serum levels of macrophage-derived chemokine and thymus and activation-regulated chemokine in autistic children
por: AL-Ayadhi, Laila Yousef, et al.
Publicado: (2013)

Validation of Neutrons in Geant4 Using TARC Data - production, interaction and transportation
por: Howard, A
Publicado: (2007)

Validation of neutrons in Geant4 using TARC data: production, interaction and transportation
por: Howard, Alexander, et al.
Publicado: (2009)

Genetics of classical Hodgkin Lymphoma
por: Schiavoni, Gianluca, et al.
Publicado: (2018)

The Intestinal Chemokine Thymus-expressed Chemokine (CCL25) Attracts IgA Antibody-secreting Cells
por: Bowman, Edward P., et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_42u2g74qtfhirqv74j3oqsqhsd